Myriad Genetics to Join S&P SmallCap 600 PR Newswire NEW YORK, Feb. 10, 2017 NEW YORK, Feb. 10, 2017 /PRNewswire/ -- Myriad Genetics, Inc. (NASD: MYGN) will replace Inteliquent, Inc. (NASD:...
CHICAGO, Feb. 10, 2017 (GLOBE NEWSWIRE) -- Inteliquent, Inc. (NASDAQ:IQNT), a premier communications enabler providing network-based voice and messaging services to wireless, cable, carrier...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Inteliquent, Inc. ("Inteliquent” or "the Company") (Nasdaq: IQNT...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of The Board of Directors of Inteliquent - IQNT PR Newswire NEW YORK, Dec. 2, 2016 NEW YORK, Dec. 2, 2016...
Lifshitz & Miller Law Firm Announces Investigation of Brocade Communications Systems, Inc., Datalink Corporation, Energy Transfer Partners, L.P., Equity One, Inc., Gas Natural Inc...
SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Inteliquent, Inc. -IQNT PR Newswire BALA CYNWYD, Pa., Nov. 23, 2016 BALA CYNWYD, Pa., Nov...
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against...
Inteliquent Inc. Acquisition May Not Be in the Best Interests of IQNT Shareholders PR Newswire NEW YORK, Nov. 7, 2016 NEW YORK, Nov. 7, 2016 /PRNewswire/ -- WeissLaw LLP is investigating possible...
Financial and operating highlights include: Company agrees to be acquired by GTCRCompany invests in Zipwhip, a Seattle-based business texting SaaS companyThird quarter 2016 minutes of use...
Ryan & Maniskas, LLP Announces Investigation of Inteliquent, Inc. PR Newswire WAYNE, Pa., Nov. 4, 2016 WAYNE, Pa., Nov. 4, 2016 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales